Skip to the page

Data / Form D filings / CellVax Therapeutics, Inc.

CellVax Therapeutics, Inc.: Form D filing

CellVax Therapeutics, Inc., a company in Miami, FL, filed a Form D with the SEC in 2024. The latest, on October 4, 2024, reports $2.1 million sold of a $5 million offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1951 NW 7TH AVENUE 3RD FLOOR, SUITE 130, Miami, FL, 33136
Phone
(215) 941-5916
Industry
Other
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2020
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2040125

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Oct 4, 2024New notice$4,999,997$2,084,999$2,914,9981Sep 19, 2024sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Fernando KreutzExecutive Officer, Director
Alberto da Costa SteinDirector

Other companies in Florida that filed recently

Every Form D from the week of Sep 30, 2024 · All recent filings in Florida · All recent Other filings

Read from SEC EDGAR. Amount sold is what CellVax Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.